about
Binding activity, structure, and immunogenicity of synthetic peptides derived from Plasmodium falciparum CelTOS and TRSP proteinsPlasmodium falciparum rhoptry neck protein 5 peptides bind to human red blood cells and inhibit parasite invasionFine mapping of Plasmodium falciparum ribosomal phosphoprotein PfP0 revealed sequences with highly specific binding activity to human red blood cells.The Plasmodium vivax rhoptry neck protein 5 is expressed in the apical pole of Plasmodium vivax VCG-1 strain schizonts and binds to human reticulocytes.Annotation and characterization of the Plasmodium vivax rhoptry neck protein 4 (PvRON4)Cell-Peptide Specific Interaction Can Inhibit Mycobacterium tuberculosis H37Rv Infection.Characterization of Plasmodium falciparum integral membrane protein Pf25-IMP and identification of its red blood cell binding sequences inhibiting merozoite invasion in vitro.PvRON2, a new Plasmodium vivax rhoptry neck antigen.Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection.Conserved regions from Plasmodium falciparum MSP11 specifically interact with host cells and have a potential role during merozoite invasion of red blood cells.Conserved regions of the Plasmodium falciparum rhoptry-associated protein 3 mediate specific host-pathogen interactions during invasion of red blood cells.A single amino acid change in the Plasmodium falciparum RH5 (PfRH5) human RBC binding sequence modifies its structure and determines species-specific binding activity.Rh1 high activity binding peptides inhibit high percentages of Plasmodium falciparum FVO strain invasion.Conserved high activity binding peptides from the Plasmodium falciparum Pf34 rhoptry protein inhibit merozoites in vitro invasion of red blood cells.Synthetic peptides from two Pf sporozoite invasion-associated proteins specifically interact with HeLa and HepG2 cellsFrom a basic to a functional approach for developing a blood stage vaccine against Plasmodium vivaxShorter Antibacterial Peptide Having High Selectivity for E. coli Membranes and Low Potential for Inducing Resistance
P50
Q27674543-13AD6D40-72A9-4246-A661-73D205CB6982Q27973874-51DEA2F7-03A0-4D69-8DA8-E00AEAEDE073Q33505350-7FBE4AA8-DEDD-485E-99F6-F36CCE3D9CAAQ35176954-1BF0B52E-C298-4F7E-B3DC-8E1937DDE2E2Q37364827-D4D5F6DD-5224-4C4C-AADC-C971C892F3C9Q38835001-6545B2A5-C673-4C13-9701-288F372EF69AQ42417080-2F5C9251-D166-4F9A-A88B-8FA8BF707DEDQ42707456-5FB3737C-D018-4D77-910F-463DC5585772Q43271064-EA507AE2-B231-4808-89AF-70BDF20777B3Q43570250-E0403F9A-209B-4441-A8F6-F1075797855DQ44308262-51A18C86-1533-4E69-A650-B2893E3A3E4EQ47995418-B7AC8297-7043-4AA3-855A-D56CE6517A2FQ48033218-3AAC9168-E6E1-4686-8DB9-00523950240AQ50569076-B7AFB27F-217D-4A19-B811-F555A4009254Q56559774-6C6F242E-FA0F-4250-B95E-B4899674E92FQ89797189-C7D57031-96E7-4BBB-9785-F0FED7EB738BQ96295007-FF0B48F1-B800-42D5-8A45-C4B7282C1F6C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gabriela Arevalo-Pinzon
@ast
Gabriela Arevalo-Pinzon
@en
Gabriela Arevalo-Pinzon
@es
Gabriela Arevalo-Pinzon
@nl
Gabriela Arevalo-Pinzon
@sl
type
label
Gabriela Arevalo-Pinzon
@ast
Gabriela Arevalo-Pinzon
@en
Gabriela Arevalo-Pinzon
@es
Gabriela Arevalo-Pinzon
@nl
Gabriela Arevalo-Pinzon
@sl
prefLabel
Gabriela Arevalo-Pinzon
@ast
Gabriela Arevalo-Pinzon
@en
Gabriela Arevalo-Pinzon
@es
Gabriela Arevalo-Pinzon
@nl
Gabriela Arevalo-Pinzon
@sl
P1053
L-8581-2016
P106
P1153
34879332700
P21
P31
P3829
P496
0000-0002-5331-5693